ArticleRSC advances2025
RSM-BBD optimization of room-temperature synthesized ZIF-8 for synergistic adsorption-photocatalysis of RhB.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three ZIF-8 nanomaterials with different Zn : 2-methylimidazole molar ratios (1 : 30, 1 : 50, and 1 : 70) were synthesized at room temperature in aqueous medium within 30 minutes without surfactants. Structural analyses confirmed the formation of mesoporous ZIF-8 with distinct morphologies, ranging from spherical assemblies to rhombic dodecahedra. Response Surface Methodology using a Box-Behnken design (RSM-BBD) was applied to optimize five parameters (pH, contact time, pollutant dose, linker amount, and catalyst weight) governing rhodamine B (RhB) removal. Under optimized conditions (pH 7, 70 mg catalyst, 10 ppm RhB, 60 min contact), ZIF-8 with a 1 : 70 ratio achieved a maximum adsorption capacity of 91.7 mg g
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.